Hesai Group
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $HSAI in the last 30 days.
See all $HSAI insider activity →Summit Therapeutics (SMMT) shares rose 10.1% to $16.07 after positive Phase III study results. Snowflake (SNOW) gained 20.6% following better-than-expected earnings. HUTCHMED (HCM) rose 13% after a licensing deal. Tesla (TSLA) increased 5.7% to $377.53. Other stocks like Robinhood (HOOD), Coinbase (COIN), and others also saw gains.
Hesai Group (HSAI) reported Q2 revenue growth of 22% YoY to RMB 861M, with lidar shipments up 78.4%. Robotics lidar shipments surged 193.4% to 142,371 units, and new robotics businesses generated first commercial revenue. The company raised full-year guidance for its Strategic Growth Initiatives segment to RMB 200-300M. Gross margin slipped to 40.1% due to lower-margin product mix, and the SGI segment posted an operating loss of RMB 64M.
Hesai Group (HSAI) shares fell 6.7% to $17.08. The GF Value™ indicates a 12.5% upside potential, suggesting undervaluation. The company has a GF Score™ of 77/100, with strong growth but weak profitability. No insider transactions were reported in the past year, and two gurus hold shares, adding to their positions.
Over the past 7 days, alphai's AI scored 1 news story mentioning HSAI (Hesai Group). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent HSAI coverage spans earnings, market movers and financial news.
Movement likely tied to sector sentiment.
Strong top‑line growth and raised guidance support upside potential, but margin compression and SGI losses add risk.
The stock's recent decline and the GF valuation highlight a potential short‑term buying opportunity but also underscore profitability concerns.
Strong earnings beat and upbeat guidance suggest upside potential, especially on the robotics segment.
Regulatory scrutiny may depress HSAI share price as investors price in potential sales restrictions.
alphai scores every news story that mentions HSAI with an AI model for sentiment and relevance, and aggregates insider trades from Hesai Group's SEC EDGAR Form 4 filings. Figures refresh continuously.
Summit Therapeutics (SMMT) shares rose 10.1% to $16.07 after positive Phase III study results. Snowflake (SNOW) gained 20.6% following better-than-expected earnings. HUTCHMED (HCM) rose 13% after a licensing deal. Tesla (TSLA) increased 5.7% to $377.53. Other stocks like Robinhood (HOOD), Coinbase (COIN), and others also saw gains.
2 min readHesai Group (HSAI) reported Q2 revenue growth of 22% YoY to RMB 861M, with lidar shipments up 78.4%. Robotics lidar shipments surged 193.4% to 142,371 units, and new robotics businesses generated first commercial revenue. The company raised full-year guidance for its Strategic Growth Initiatives segment to RMB 200-300M. Gross margin slipped to 40.1% due to lower-margin product mix, and the SGI segment posted an operating loss of RMB 64M.
3 min readHesai Group (HSAI) shares fell 6.7% to $17.08. The GF Value™ indicates a 12.5% upside potential, suggesting undervaluation. The company has a GF Score™ of 77/100, with strong growth but weak profitability. No insider transactions were reported in the past year, and two gurus hold shares, adding to their positions.
2 min readHesai (HSAI) reported Q2 2026 revenue of RMB 861M ($127M), up 22% YoY, with net income of RMB 71M ($10M), up 60%. Lidar shipments rose 78.4% YoY to 628,275 units. The company raised guidance for SGI revenue and expects Q3 revenue of RMB 1.1B-1.15B. Hesai maintains 44% market share in China's ADAS lidar market and is expanding into robotics.
2 min readThe U.S. is investigating Chinese lidar sensors for potential cybersecurity risks, with Idaho National Laboratory testing their vulnerability to hacking. Automakers like Rivian, GM, and Ford claim no knowledge of the review, while Hesai's shares trade below their 52-week high amid regulatory concerns. The outcome could impact lidar suppliers and automaker strategies.
3 min readHesai Group (HSAI) reported Q2 revenue of RMB860.8M, up 21.9%, with net income rising 60% to RMB70.6M. LiDAR shipments increased 78.4% to 628,275 units. The company's Strategic Growth Initiatives (SGI) lost RMB64.0M, while LiDAR generated RMB66.2M in operating profit. Hesai raised 2026 SGI revenue guidance to RMB200M-RMB300M and expects breakeven in 2027. The company reported RMB7.05B in liquidity as of June 30.
2 min readHesai Group (NASDAQ:HSAI) said on its Q2 earnings call it won a mass-production LiDAR design win with Great Wall Motor, with production expected in late 2026, and secured additional programs with Changan Automobile and Volkswagen. Management cited Gasgoo data showing 44% share of China long-range ADAS LiDAR in June. SGI generated RMB 45m revenue in Q2; full-year 2026 SGI outlook raised to RMB 200m-300m. Q3 revenue forecast is RMB 1.1-1.15b and LiDAR shipments 800k-850k; FY2026 LiDAR 3.0-3.5m.
6 min readHesai Group (NASDAQ: HSAI; HKEX: 2525) reported Q2 2026 unaudited results for the three months ended June 30. Net revenues were RMB860.8 million (US$126.9 million) and net income RMB70.6 million (US$10.4 million). Lidar shipments were 628,275 units. The company raised full-year 2026 SGI revenue guidance to RMB200-300 million.
7 min readHesai Group (NASDAQ: HSAI) reported Q2 2026 net revenues of RMB 861 million (US$127 million), up 22% year over year, and GAAP net income of RMB 71 million (US$10 million), up 60%. Gross margin was 40%. LiDAR shipments rose to 628,000 units (+80%). Q3 revenue guidance is $162 million to $169 million.
3 min readHesai (HSAI) raised its SGI revenue guidance to RMB 200mn–300mn for FY2026 from RMB 100mn, citing faster commercialization. Management expects SGI breakeven in 2027 and lidar shipments of 3.0mn–3.5mn units. In Q3, revenue was RMB 861mn (+22% YoY) with GAAP net profit RMB 71mn.
6 min read
